2017
DOI: 10.1021/acs.jafc.7b00326
|View full text |Cite
|
Sign up to set email alerts
|

Formation of a Multiligand Complex of Bovine Serum Albumin with Retinol, Resveratrol, and (−)-Epigallocatechin-3-gallate for the Protection of Bioactive Components

Abstract: Clarification of the interaction mechanisms between proteins and bioactive components is important to develop effective carriers for encapsulation and protection of bioactive components. Bovine serum albumin (BSA), a globular protein in serum and milk, contains multiple sites to bind a variety of low-molecular-weight molecules, forming protein-monoligand complexes. In this study, the interactions of BSA with retinol, resveratrol, and/or (-)-epigallocatechin-3-gallate (EGCG) were investigated by using fluoresce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

6
73
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 58 publications
(84 citation statements)
references
References 40 publications
6
73
0
Order By: Relevance
“…Three homologous domains build up BSA, which is called as domain I, II, and III. Each domain is divided into two subdomains (A and B) [1,2].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Three homologous domains build up BSA, which is called as domain I, II, and III. Each domain is divided into two subdomains (A and B) [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…BSA has been widely used as drug delivery device because of its non-toxicity, biodegradability, nonimmunogenicity, water solubility, availability and its low cost, because large quantities of it can be readily purified from bovine blood [3]. In order to be used as drug delivery device, BSA has been bound with ligand complex [1] and polymer [4], or complexed with magnetic iron oxide [5].…”
Section: Introductionmentioning
confidence: 99%
“…Combinations of different antioxidants have the potential to reduce the toxicity or pro‐oxidation of bioactive compounds delivered at high doses. However, such combinations may give rise to antagonistic, additive or synergistic effects on the bioactivity and stability of the compounds (Wang et al ., 2011; Wu et al ., 2017). It is important to identify such interactions and their mechanisms in order to facilitate the formulation of high‐quality functional products.…”
Section: Introductionmentioning
confidence: 99%
“…A few studies have demonstrated that EGCg competes with 5-fluorouracil and related drugs for binding sites on serum albumin [30,33]. However, EGCg, resveratrol, and retinol simultaneously bind serum albumin at unique binding sites with minimal structural or chemical cross-talk between the ligands [34]. A knowledge gap that limits exploitation of the pharmaceutical potential of EGCg is poor understanding of how natural endogenous ligands of serum albumin combined with exogenous ligands such as EGCg affect the protein.…”
Section: Introductionmentioning
confidence: 99%